Yudong Su - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yudong Su

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021

Anlotinib Induces a T Cell-Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in NeuroblastomaYudong Su, Bingying Luo, Yao Lu, et al.

Cancer Biology & Medicine|September 23, 2021

EZH2 identifies the precursors of human natural killer cells with trained immunityChen Zhang, Jie Yin, Jian Zheng, et al.

Targeted Oncology|March 22, 2019

Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with CrizotinibYudong Su, Xiang Long, Yang Song, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2021

Cancer Biology & Medicine|September 23, 2021

EZH2 identifies the precursors of human natural killer cells with trained immunityChen Zhang, Jie Yin, Jian Zheng, et al.

Targeted Oncology|March 22, 2019

Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with CrizotinibYudong Su, Xiang Long, Yang Song, et al.

Pageof 3